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Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IllinoisABSTRACT Antimycin A is the most frequently used specific and powerful inhibitor of the mitochondrial respiratory chain. We
used all-atommolecular dynamics (MD) simulations to study the dynamic aspects of the interaction of antimycin A with the Qi site
of the bacterial and bovine bc1 complexes embedded in a membrane. TheMD simulations revealed considerable conformational
flexibility of antimycin and significant mobility of antimycin, as a whole, inside the Qi pocket. We conclude that many of the differ-
ences in antimycin binding observed in high-resolution x-ray structures may have a dynamic origin and result from fluctuations of
protein and antimycin between multiple conformational states of similar energy separated by low activation barriers, as well as
from the mobility of antimycin within the Qi pocket. The MD simulations also revealed a significant difference in interaction
between antimycin and conserved amino acid residues in bovine and bacterial bc1 complexes. The strong hydrogen bond
between antimycin and conserved Asp-228 (bovine numeration) was observed to be frequently broken in the bacterial bc1
complex and only rarely in the bovine bc1 complex. In addition, the distances between antimycin and conserved His-201 and
Lys-227 were consistently larger in the bacterial bc1 complex. The observed differences could be responsible for a weaker inter-
action of antimycin with the bacterial bc1 complex.INTRODUCTIONThe cyt bc1 complex plays a central role in free-energy trans-
duction in all major electron-transfer chains (1–3). Cyt bc1
complex oxidizes lipophilic quinone, reduces water-soluble
cytochrome, and generates a transmembrane electrochemical
gradient of protons (1–7). The cyt bc1 complex is a homo-
dimer (2) that operates through a Q-cycle mechanism (8–10).
The functional core of each monomer (Fig. 1) contains two-
heme cytochrome b, cytochrome c1, Rieske iron-sulfur
protein, and two quinone-processing sites for oxidation of
ubiquinol (Qo site) and reduction of ubiquinone (Qi site).Antimycin inhibition
Over the years, specific inhibitors of the bc1 complex have
played a significant role in elucidating the electron transport
mechanisms inside the complex. Antimycin A, a natural
product of Streptomyces, is the most frequently used specific
and powerful inhibitor of the mitochondrial respiratory
chain (13–17).Submitted September 16, 2010, and accepted for publication December 13,
2010.
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0006-3495/11/02/0720/9 $2.00Antimycin is a very tight inhibitor in the mammalian bc1
complex (14,18). The affinity of antimycin for the bc1
complex of purple bacteria is 1–2 orders of magnitude
less than that in the bovine bc1 complex (19). The essence
of antimycin’s action consists of competitive displacement
of ubiquinone from the Qi site (2,3,20). The competitive
nature of antimycin A inhibition has been confirmed
directly by crystallographic structures of the bc1 complex
(12,17,21). However, the tight binding affinity of antimycin
is not fully understood, and the dynamics of antimycin’s
interaction with the Qi site are practically unknown.Structural features of antimycin A required for
inhibitory action, as revealed by structure-activity
studies
Antimycin A consists of three parts (Fig. 2): a FASA
moiety; a dilactone ring connected to FASA via an amide
bond; and acyl and alkyl chains attached to the dilactone
ring. Previous tests of the inhibition of electron transport
by a series of antimycin analogs indicated that the FASA
moiety and the immediately adjacent groups are most essen-
tial for its inhibitory activity, and that the remaining dilac-
tone portion is important mostly for providing proper
solubility in lipid (22–26).Binding of antimycin to the isolated bc1 complex,
as indicated by structures
At least six structures of the bc1 complex from several
species with antimycin at the Qi site have been depositeddoi: 10.1016/j.bpj.2010.12.3705
TABLE 1 Distances between different atoms of antimycin and
conserved amino acid residues of the Qi site (in bovine
numeration) in different PDB structures (12,17,21)
Atom in amino acid residue
Atom in
antimycin
Distance, A˚
1PPJ 1NTK 2QJP
OD1, OD2 of Asp-228* N1 2.8, 3.7 3.0, 3.8 2.8, 3.8
N2 4.3, 5.8 5.3, 6.8 4.2, 5.7
O1 4.4, 5.8 6.0, 4.9 4.5, 5.8
O2 2.6, 3.4 2.3, 2.9 2.6, 3.2
O3 6.3, 7.6 3.2, 4.8 6.0, 7.4
NZ of Lys-227 O1 5.2 3.7 4.6
NE2 of His-201 O3 4.1 7.7 4.4
N2 6.1 5.6 6.4
O5 5.0 5.5 5.5
*Asp-228, Lys-227, and His-201 in the bovine bc1 complex (1PPJ, 1NTK)
are homologous to Asp-252, Lys-251, and His-217, respectively, in the
bacterial bc1 complex (2QJP).
FIGURE 1 Structure of the bacterial bc1 complex with cofactors. The
figure was prepared with VMD software (11) using the 2QJP structure (12).
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and 1NTK (21) have resolution better than 2.7 A˚. Although
there is good overall agreement among these structures,
there are many differences in the arrangement of side chains
(see Table 1), the number and position of the crystallo-
graphic water molecules involved in antimycin binding,
the type and number of hydrogen bonds, and the conforma-
tion of antimycin (12,17,21).
The alignment of the different high-resolution structures
of the bc1 complex obtained with the program STAMP
(28), as implemented in VMD software (11), reveals the
following differences in binding of antimycin:
1. The positions of the phenolic oxygen (O2) and oxygen of
the amide bond (O3) of antimycin (see Fig. 2) are in theFIGURE 2 (A) Structure of antimycin A1 with numeration of oxygen and
nitrogen atoms as employed in the x-ray 2QJP structure. Note that this
numeration is different from other structures (see, e.g., 1PPJ) and from
chemical (IUPAC) nomenclature. (B) The anti conformation of antimycin
(with respect to O2 and O3) modeled in the 1PPJ (17) and 2QJP (12) struc-
tures. (C) The syn conformation modeled in the 1NTK structure (21) and
antimycin A1 crystals (27).anti conformation in the 1PPJ and 2QJP structures, and
in the syn conformation in the 1NTK structure (the syn
conformation is also found in crystals of antimycin A1
(27)). This conformation is important for the pattern of
hydrogen bonding of antimycin and neighboring amino
acid residues and water molecules.
2. All high-resolution structures differ in the number and
position of crystallographic waters.
3. The positions and orientations of the ring of conserved
His-201, as well as the patterns of its interaction with
antimycin, are significantly different among the struc-
tures. Although His-201 forms a water-mediated
hydrogen bond with N2 of antimycin in 1NTK, it forms
a water-mediated hydrogen bond to O3 of antimycin in
1PPJ, and does not interact with water molecules or
form a hydrogen bond with antimycin at all in the
2QJP structure.
4. There is a significant variability in the position of
conserved Lys-227 and its interaction with antimycin
among the structures. In particular, Lys-227 forms
a weak hydrogen bond with O1 of antimycin in 1NTK,
and is hydrogen-bonded via water to the O1 atom in
the 1PPJ structure, but it does not form either a direct
or a water-mediated hydrogen bond in 2QJP.
It is not currently clear whether these differences are due
to differences in the crystallization conditions and the type
of crystals used, differences between species, the omission
of water molecules in the x-ray structure refinement, or
the dynamic interaction of antimycin with the bc1 complex.Significance of this study
It is well known that quinone-binding sites of membrane
complexes are primary targets for antibiotics, fungicides,
insecticides, and herbicides (29), and the interaction of anti-
biotics with the quinone-binding sites of proteins is one of
the main topics in modern biochemistry and biophysics.Biophysical Journal 100(3) 720–728
TABLE 2 Summary of the MD simulations of bc1 complex in
membrane performed in this work
No. Species
Protein
PDB file
Number
of atoms Time (ns)
Initial
conformation
of antimycin*
1 Bos taurus 1PPJ 384225 7.6 anti
2 Bos taurus 1PPJ 384225 3.7 anti
3 Bos taurus 1PPJ 384225 3.8 anti
4 Rb. sphaeroides 2QJP 202104 10.2 anti
5 Rb. sphaeroides 2QJP 202104 10.1 anti
6 Rb. sphaeroides 2QJP 188433 9.6 syn
7 Rb. sphaeroides 2QJP 202083 10.6 syn
*See Fig. 2 for definition of anti and syn conformations of antimycin.
722 Kokhan and ShinkarevHere, we used MD simulations to characterize the dynamic
interaction of antimycin with bacterial and bovine bc1
complexes. During the MD simulations, we sought answers
for the following questions:
What is the nature of the antimycin conformation in the
Qi site?
Does antimycin have a significant mobility after it is
bound to the Qi site?
Could the differences in antimycin binding observed
in different crystal structures originate from the
dynamics (mobility, fluctuations, different conforma-
tional substates, etc.) of antimycin in the Qi site of
the bc1 complex?
How strong are the hydrogen bonds between antimycin
and conserved amino acid residues?
What are the differences in the interaction of antimycin
with the bacterial and mammalian proteins?
To our knowledge, this is the first all-atom MD study of
an inhibitor molecule bound to the mammalian or bacterial
bc1 complex dimer in membrane.MATERIALS AND METHODS
CHARMM parameters for antimycin
CHARMM force-field parameters for antimycin were derived as follows:
atom coordinates for antimycin A1 were taken from the 2QJP structure
and the geometry of the molecule corresponding to the lowest-energy state,
and charges were calculated at the B3LYP/6-31G* level using Firefly soft-
ware (30). All new bond lengths, angles, and dihedrals (not available in
the standard CHARMM 27 force field) were based on the optimized anti-
mycin structure. All new force constants were derived by analogy from
those already available for similar bonds, angles, and dihedrals present in
CHARMM 27.FIGURE 3 RMSDs for trajectories of the antimycin headgroup (phenyl
ring) in the Qi site of mammalian (A) and bacterial (B) bc1 complexes.
Data for Fe of the nearest bH heme are shown for comparison. Data are
shown for both antimycin molecules bound to the respective monomer.
RMSDs were calculated after backbone alignment of the cyt b subunits
to the x-ray structure, using the RMSD Trajectory Tool plugin in VMD
(11). Numbers near each trajectory correspond to the MD simulations in
Table 2; the two antimycin molecules in the same bc1 dimer are marked
by letters a and b. All data sets in this and other figures begin at zero
time, but are shifted horizontally to show all of them simultaneously.MD simulations
MD simulations of antimycin bound to the Qi sites of either bovine (PDB:
1PPJ) or bacterial (PDB: 2QJP) bc1 complex were set up with the addition
of a palmitoyl-oleoyl phosphatidylcholine membrane and water box using
VMD 1.8.7 (11). Each cyt b monomer contained one antimycin molecule
bound to the Qi site. Initially all atoms, except those located in the lipid
tails, were fixed and the system was brought to 310 K and equilibrated
for 200 ps at T¼ 310 K and constant system volume. Then, only nonhydro-
gen atoms of the protein, cofactors, and antimycin were restrained and the
system was packed for 300 ps at T ¼ 310 K and P ¼ 1 atm. All simulations
were performed with NPT¼const settings (constant pressure, (P ¼ 1 atm),
constant temperature (T ¼ 310 K), and fixed number of particles (N)) with
the CHARMM 27 force field (31) and the following NAMD parameters:
1 fs time step and 12 A˚ cutoff distance for nonbonded nonelectrostatic inter-
actions calculated every two steps. Electrostatic forces were calculated with
the particle mesh Ewald approach (32) every four steps. A Langevin bath
and piston were used to maintain temperature and pressure. Atom coordi-
nates were saved every 0.01 ns.
Simulations (see Table 2) were performed on the Turing cluster operated
by the Computational Science and Engineering program at the University of
Illinois, using NAMD (33). Some simulations and data analysis were also
performed on a computer with a quad core i7 CPU and NVIDIA Geforce
GTX 295 video card.Biophysical Journal 100(3) 720–728RESULTS
RMSD for the headgroup of antimycin in the Qi
site of the bc1 complex
On the basis of their high-resolution crystal structure of the
cyt bc1 complex, Gao et al. (21) concluded that ‘‘antimycin
A1 is conformationally rigid with practically only one flex-
ible dihedral angle bridging the 3-FASA group and the
dilactone ring between the atoms C9 and N2.’’ Yet, our
MD simulations revealed that the antimycin structure is
relatively flexible. Moreover, antimycin also has consider-
able mobility, as a whole, in the Qi pocket (Fig. 3).
The MD simulations of antimycin-bc1 complexes re-
vealed that antimycin has significant mobility compared
with some other components of the bc1 complex. In most
cases, the RMSDs of the center of the antimycin headgroup
from the initial positions in the Qi site of bacterial (2QJP)
FIGURE 4 RMSDs for trajectories of individual functional atoms (N2,
O2, and O3) in antimycin bound to mammalian (A–C) and bacterial
(D–F) bc1 complexes, as observed in different MD simulations (see
Table 2). Data are shown for both antimycin molecules bound to the bc1
complex dimer. MD simulations trajectories are marked by the numbers
shown in Table 2; the two antimycin molecules in the same bc1 dimer are
marked by letters a and b.
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larger than the RMSD of the trajectories of Fe of the nearest
bH heme (Fig. 3). The irregular movement of the antimycin
A headgroup, such as seen in traces 1a, 5b, and 7b, origi-
nates from the stochastic nature of the MD simulation and
is caused by many factors, including the redistribution of
hydrogen bonds with the protein, fluctuations in the posi-
tions of surrounding amino acid residues, changes in the
number and position of water molecules near antimycin,
and interaction of nearby lipid molecules with the antimycin
tail.
It is important to note that the RMSD trajectories were
calculated after each alignment of the MD structures with
the original x-ray structure. Thus, the observed systematic
shifts in trajectories (Fig. 3) are indicative of systematic
differences in the structures of the bc1 complex embedded
in membrane compared with the crystallographic structure
of the bc1 complex. Therefore, on average, the position of
Fe of the nearest bH heme (associated with the Qi site) is
shifted from that in the x-ray structure by ~1 A˚. Similarly,
the average position of antimycin in the case of the
membrane-embedded bc1 complex is shifted from that in
the respective crystallographic structure by at least 1.5 A˚.
In addition to this systematic shift, one can also see irregular
movement of the antimycin headgroup, which is especially
large in some simulations of the bacterial bc1 complex.
Because the antimycin headgroup is heavier than Fe, this
movement of the antimycin headgroup in the protein on
a nanosecond timescale indicates the presence of many
energy-equivalent states with low activation barriers. This
observation could explain, at least partially, the differences
in the position of antimycin in the published structures.Mobility of individual functional atoms
of antimycin
The MD simulations also revealed that individual functional
atoms of antimycin had significant mobility (Fig. 4), which
in some cases was different from that of the headgroup. In
particular, traces 2b and 5a in Fig. 4, C and F, respectively,
show that in some cases the RMSD values of O3 (see struc-
ture of antimycin on Fig. 2) are significantly higher than the
RMSDs of other atoms, indicating their conformational
flexibility. One can also see that the RMSDs of individual
atoms differ significantly for the two antimycin molecules
bound to different monomers of the bc1 complex dimer
(compare trajectories a and b).Different conformations of antimycin
After analyzing the inhibiting effect of antimycin analogs,
Miyoshi and co-authors (26) suggested that the intramolec-
ular hydrogen bond between the phenolic OH and the
peptide carbonyl is important for antimycin inhibitor
activity. This hydrogen bond could be observed only inthe syn conformation (see Fig. 2 C). Although this confor-
mation was observed in antimycin A1 crystals (27), and
was successfully used to model antimycin in the 1NTK
PDB structure with 2.6 A˚ resolution (21), in the highest-
resolved structure (1PPJ) of the bc1 complex with 2.1 A˚
resolution, antimycin was modeled by the anti conformation
(see Fig. 2 B).
We used MD simulations to explore changes that
occurred in the antimycin conformation in the Qi site as a
function of time. To do this, we measured distances
between O2 of the phenyl ring of antimycin and N2, and
between O2 and O3, as well as the value of dihedral angle
O2-C7-C8-N2 (see Fig. 2 C for definition of C7 and C8)
in the MD trajectories (Fig. 5).
MD simulations of the bovine bc1 complex starting with
the anti conformation of antimycin revealed that most of the
time the distance between N2 of the amide bond and O2 of
the phenyl ring of antimycin was less than that between O3
and O2 of the antimycin (Fig. 5 A). Similarly, the absolute
value of the dihedral angle O2-C7-C8-N2 (see Fig. 2 C
for definition of C7 and C8) most of the time was <45.
Particular values of distances between O2 and N2, and
between O2 and O3, as well as the dihedral angle O2-C7-
C8-N2 in different simulations are shown in Table 3. Only
occasionally did the distance between O3 and O2 approach
that between N2 and O2 (see trajectory 2b in Fig. 5 A), andBiophysical Journal 100(3) 720–728
FIGURE 5 Distances between O2 and N2 and between O2 and O3 atoms
of antimycin (A and C), as well as the dihedral angle O2-C7-C8-N2 (B and
D), as observed in different MD simulations (see Table 2) of the bovine (A
and B) and bacterial (C and D) bc1 complexes. Trajectories of MD simula-
tions are marked as in Table 2; the two antimycin molecules in the same bc1
dimer are marked by letters a and b. In simulations 1–5, antimycin was
initially in the anti conformation (relative to O2 and O3; see Fig. 2),
whereas in simulations 6 and 7, antimycin was initially in the syn confor-
mation.
724 Kokhan and Shinkarevthe absolute value of the dihedral angle O2-C7-C8-N2
exceed 80 (see trajectory 2b in Fig. 5 B). Thus, the MD
simulations of the bovine bc1 complex indicate the presence
of a whole spectrum of positions of N2 and O3, as well as
dihedral angles, most of which are different from the initial
anti conformation of antimycin modeled in the x-ray struc-
tures of the bc1 complex.
TheMD simulations of the bacterial bc1 complex (starting
with the anti conformation of antimycin) showed that three
out of four simulations were similar to those seen in the
bovine bc1 complex, in that the distance between N2 of theTABLE 3 Average distances betweenO2 and N2, and between
O2 and O3, as well as the dihedral angle O2-C7-C8-N2 (Fig. 2 C)
in antimycin in different MD simulations, calculated from data
shown in Fig. 5
No.
Subunit,
carrying
antimycin
Distance
O2-N2, A˚
Distance
O2-O3, A˚
Dihedral angle
O2-C7-C8-N2,
degree
Starting
antimycin
conformation
1 C 2.75 0.1 4.25 0.1 9.15 20.1 anti
P 2.75 0.1 4.25 0.1 2.55 20.0
2 C 2.75 0.1 4.25 0.1 9.55 14.2 anti
P 2.95 0.2 4.05 0.2 35.45 24.6
3 C 2.75 0.1 4.25 0.1 4.55 14.1 anti
P 2.75 0.1 4.25 0.1 10.35 14.9
4 A 3.15 0.2 3.95 0.2 48.45 18.2 anti
D 2.95 0.2 4.15 0.2 33.85 19.3
5 A 3.15 0.2* 3.95 0.2* 52.55 15.9* anti
A 3.75 0.2y 3.35 0.2y 82.45 14.1y
D 3.05 0.3 4.05 0.2 37.05 21.9
6 A 3.85 0.2 3.45 0.2 89.35 14.5 syn
D 4.05 0.2 3.05 0.3 111.45 23.3
7 A 3.75 0.4 3.45 0.3 88.15 26.3 syn
D 3.95 0.2 3.15 0.2 100.75 18.4
*Calculated for trajectory before 2.9 ns.
yCalculated for trajectory after 2.96 ns.
Biophysical Journal 100(3) 720–728amide bond and O2 of the phenyl ring of antimycin
was less than that between O3 and O2 of the antimycin
(Fig. 5C, trajectories 4a, 4b, and 5b). However, even in these
simulations, both the average values of these distances and
the standard deviations were significantly different from
those of the bovine bc1 complex (see Fig. 5 and Table 3).
Of most importance, during the MD simulations of the
bacterial bc1 complex, we observed an anti-syn interconver-
sion of the antimycin conformation (Fig. 5, trajectory 5a).
In particular, one can see that before ~2.9 ns the N2-O2
distance was less than the O3-O2 distance, and the average
dihedral angle O2-C7-C8-N2 was ~50. However, after
2.9 ns the antimycin is converted to a conformation in which
the distance between O2 and N2 is larger than that between
O2 and O3, and the average dihedral angle O2-C7-C8-N2 is
~80 (see Table 3).
To confirm the importance of the initial conformation of
antimycin, we repeated the MD simulation of the bacterial
bc1 complex starting with the syn conformation of antimy-
cin, instead of the anti conformation. The results of these
simulations are shown in Fig. 5 (trajectories 6 and 7). As ex-
pected, the MD simulations show that with the syn starting
conformation, the antimycin mostly stays in conformations
resembling the original syn conformation, in which the
distance between O2 and N2 is larger than the distance
between O2 and O3, and the dihedral angle O2-C7-C8-N2
has a value of ~80 (see Table 3). One can also see a short,
reversible syn/anti/syn interconversion in trajectory 7a
(Fig. 5 D).
Thus, the 10 nsMDsimulations show that inmost cases the
antimycin stays in conformations resembling the original
starting conformation. Only in rare cases did we observe
interconversion between the anti and syn conformations of
antimycin (see trajectories 5a and 7a in Fig. 5). These
observed transitions strongly indicate that although the start-
ing conformation of antimycin in the bc1 complex structure
is significantly important for subsequent conformations of
the antimycin on the short timescale, the energy barrier
between these conformation is not that high, and practically
any values of the dihedral angle O2-C7-C8-N2 could be
observed in MD simulations (especially for the bacterial
bc1 complex) on a nanosecond timescale. The particular
conformation depends on many factors, including the
formation of a hydrogen bond between antimycin and
protein. The observed different conformations of antimycin
in bovine and bacterial bc1 complexes (see Fig. 5 and
Table 3) indicate that the binding of antimycin in the Qi
site leads to modification of its conformation pattern.Multiple positions of antimycin and functional
atoms of the conserved amino acid residues
in aligned structures
The MD simulations showed the presence of multiple posi-
tions and conformations of antimycin at the Qi site, as well
Molecular-Dynamics Simulations of Antimycin A at the Qi Site 725as the positions of the conserved amino acid residues. Fig. 6
shows antimycin and functional atoms (O and N) of the
conserved amino acid residues in bovine (A and B) and
bacterial (C–F) bc1 complexes for every 0.5 ns of MD simu-
lations. The two antimycin molecules in the same bc1 dimer
are shown in different panels of the same row. All structures
were aligned by the antimycin headgroup. In such aligned
structures, the more strongly an amino acid residue interacts
with the antimycin, the more compact is the position of this
group in overlaid structures.
The figure illustrates that fixation of the phenol head-
group still allows a significant mobility of other parts of
the antimycin molecule bound in the Qi pocket. It is impor-
tant to note that because multiple conformations of the
antimycin were observed on the nanosecond timescale, the
activation barrier for transition between these conforma-
tions should be relatively small.FIGURE 6 Overlaid structures of antimycin and functional atoms of
the conserved amino acid residues in bovine (A and B) and bacterial (C–F)
bc1 complexes obtained in MD simulations. Antimycin molecules are
numbered as in Table 2. The two antimycin molecules in the same bc1
dimer are marked by letters a and b. All structures were aligned by the
phenol ring (carbons only) of the respective antimycin molecule. The
positions of antimycin and functional atoms (O and N) of the conserved
amino acid residues are shown for every 0.5 ns of MD simulation. Shown
are OD1 and OD2 of Asp-228, NZ of Lys-227, and ND1 and NE2 of
His-201 (bovine numeration). All antimycin structures except the first
one are dimmed.In the case of the bovine bc1 complex (Fig. 6, A and B),
the positions of OD1 and OD2 of Asp-228 form compact
distributions located near both O2 and N1 of antimycin.
NZ of Lys-227 forms a compact distribution in one mono-
mer (B) and a slightly less compact distribution in the other
monomer (A). The positions of ND1 and NE2 of His-201 are
quite scattered in one monomer (A) but form a more com-
pact distribution in the other monomer (B). Thus, in both
monomers antimycin shows similar patterns of interaction
with the conserved amino acid residues, although some
differences in the distances between functional atoms of
the conserved amino acid residues and antimycin can be
seen between monomers.
Fig. 6 also shows overlaid structures of the bacterial bc1
complex, obtained by MD simulations starting with anti
(C and D) or syn (E and F) conformations of antimycin.
The pattern of interaction of antimycin with the con-
served amino acid residues in the bacterial bc1 complex,
obtained by MD simulations starting with the anti confor-
mation (Fig. 6, C and D), is similar to that observed in the
bovine bc1 complex starting with the anti conformation
(compare panels A and B with panels C and D). How-
ever, one can see greater scatter in the positions of the func-
tional atoms of His-201, Lys-227, and Asp-228 (bovine
numeration).
MD simulations of the bacterial bc1 complex starting with
the syn conformation of antimycin (Fig. 6, E and F) reveal
different patterns of interaction of antimycin with the
conserved amino acid residues. Indeed, in this case NZ of
the conserved Lys-227 is located closer not only to O1 but
also to O2 of antimycin. Similarly, OD1 and OD2 of Asp-
228 in many cases are closer to N2 than to N1, in contrast
to the situation observed in the anti conformation.
The different patterns of interaction of antimycin con-
formers with the conserved amino acid residues, together
with the observation that different conformations of antimy-
cin are accessible on a nanosecond timescale, strongly indi-
cate that similar changes in the pattern of interaction could
be a part of the catalytic cycle of the Qi site.Strong hydrogen bond between conserved
Asp-228 and O2 of antimycin
The MD simulations consistently show the presence of
a strong hydrogen bond between Asp-228 and antimycin
in all simulations starting with the anti conformation of
the antimycin (see traces 1–5 in Fig. 7). Only in trajectory
5b is this hydrogen bond irreversibly lost during the simula-
tion, consistent with a significant displacement of the anti-
mycin headgroup (Fig. 3). However, this hydrogen bond
was frequently broken in all simulations starting with the
syn conformation of antimycin (traces 6 and 7 in Fig. 7).
Both OD1 and OD2 atoms of Asp-228 are capable of
forming a hydrogen bond with O2 of antimycin, and
multiple switching between OD1 and OD2 was observedBiophysical Journal 100(3) 720–728
FIGURE 7 Minimal distance between functional oxygen atoms OD1 and
OD2 of the conserved Asp-228 (bovine numeration) and O2 of antimycin in
bovine (A) and bacterial (B) bc1 complexes during MD simulations. The
trajectories of MD simulations are marked as in Table 2; the two antimycin
molecules in the same bc1 dimer are marked by letters a and b. In simula-
tions 1–5, antimycin was initially in the anti conformation (relative to O2
and O3, see Fig. 2), whereas in simulations 6 and 7, antimycin was initially
in the syn conformation.
726 Kokhan and Shinkarevduring the MD simulations. Fig. 7 shows the minimal
distance between oxygen atoms OD1 and OD2 of the con-
served Asp-228 (bovine numeration) and O2 of antimycin
in bovine (A) and bacterial (B) bc1 complexes during the
simulations. Only rarely (see traces 1a and 2b) can one
observe a significant increase of this distance in the bovine
bc1 complex. The situation is somewhat different in the case
of the bacterial bc1 complex, where one can see frequent
increases of this distance, corresponding to a breakage of
the hydrogen bond(s) between Asp-228 (bovine numera-
tion) and antimycin.DISCUSSION
Antimycin conformers and their interconversion
In this work we used MD methods to test the dynamics of
antimycin binding inside the Qi pocket of membrane-
embedded bc1 complex and interconversion between anti-
mycin conformers. MD simulations of bovine and bacterial
bc1 complexes starting with the anti conformation of anti-
mycin reveal that on a short timescale, the antimycin stays
in a similar conformation in which the distance between
N2 of the amide bond and O2 of the phenyl ring of antimy-
cin is less than that between O3 and O2 of the antimycin
(Fig. 5, A and C; Table 3). It is important to note that the
MD simulations indicate the presence of a whole spectrum
of positions of N2 and O3, as well as dihedral angles,
most of which are different from the initial anti conforma-
tion of antimycin (see Table 3 for details). Moreover, the
MD simulations reveal occasional interconversions between
different conformations of antimycin.
MD simulations of the bacterial bc1 complex starting with
the syn conformation show that most of the time, the anti-
mycin stays in conformations resembling the original synBiophysical Journal 100(3) 720–728conformation, in which the distance between O2 and N2
is larger than the distance between O2 and O3 (see Table 3).
Thus, the MD simulations show that on a short timescale,
in most cases the antimycin stays in conformations
resembling the original starting conformation. Only in
rare cases were interconversions between anti and syn
conformations observed (see trajectories 5a and 7a in
Fig. 5). The observed interconversions of antimycin bound
at the Qi site strongly indicate that the energy barriers
between these conformations are not that high, and that
practically any values of dihedral angle O2-C7-C8-N2 could
be observed in MD simulations. The particular value of
the dihedral angle depends on many factors, including
the formation of hydrogen bonds between antimycin and
protein.
Thus, the MD simulations reveal the whole spectrum of
positions of N2 and O3 of antimycin, not just those modeled
in the x-ray structures of the bc1 complex, as well as transi-
tions between different conformers.Comparison of the binding of antimycin in bovine
and bacterial bc1 complexes
The stochastic nature of MD simulations leads to consider-
able variability of individual trajectories. As a result, signif-
icant differences are observed even during repetitions of the
same simulation. The high variability of MD simulations
makes it difficult to compare different proteins without
proper controls and references. To reduce this variability,
we aligned all frames obtained by MD simulations using
either the backbone atoms (Figs. 3–5 and 7) or the head-
group of antimycin (Figs. 6 and 8). The structures aligned
by the antimycin headgroup provide a clearer picture of
the differences observed between species.
Fig. 8 shows the percentage of time that different amino
acid residues were within 3.5 A˚ of antimycin during the
MD simulations of bovine (A) and bacterial (B) bc1 com-
plexes. Only those amino acid residues for which the occu-
pation time exceeded 50% in at least one monomer in either
the bovine or bacterial bc1 complex are shown.
Many of the amino acid residues that were found to be in
close contact with antimycin during the MD simulations
have been implicated in antimycin resistance in different
species (12,21). Replacement of Gly-38 (bovine numera-
tion) by valine in yeast and mouse proteins was shown to
lead to antimycin resistance (34,35), and it was suggested
that species that have alanine in this position, such as
Rb. sphaeroides, might also exhibit an increase in antimycin
resistance (35,36). This and other natural mutations in
Rb. sphaeroides may explain why antimycin has no signifi-
cant effect on the photosynthetic growth of this bacterium
(36).
Fig. 8 illustrates a significant similarity between compo-
nents of the Qi sites responsible for binding of antimycin in
bovine and bacterial bc1 complexes. In both cases, the
FIGURE 8 (A and B) Percentage of time that different amino acid resi-
dues (bovine numeration) were within 3.5 A˚ of antimycin during MD simu-
lations of bovine (A, No. 1 in Table 2) and bacterial (B, No. 4 in Table 2) bc1
complexes. (C) The absolute value of the differences of averaged occupan-
cies between bovine and bacterial bc1 complexes. The two monomers are
indicated by gray and black bars. The numeration of amino acid residues
in the bacterial bc1 complex is shown in brackets. Amino acid residues
implicated in antimycin A resistance (12,21,37,38) are marked by bold font.
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197, Gly-38, and Ser-35 (bovine numeration) are >90%.
For conserved His-201, the occupancy is close to zero
in the case of the bacterial bc1 complex, and >70% in the
case of the bovine bc1 complex. The occupancy of con-
served Lys-227 is also somewhat smaller in the bacterial
bc1 complex. The larger distances between antimycin and
conserved His-201 and Lys-227 could be responsible, along
with other factors, for differences in the binding of antimy-
cin in bovine and bacterial bc1 complexes seen in the MD
simulations.
The figure also illustrates that in some cases, the contact
with amino acid residues can be significantly different for
the two antimycin molecules in the same bc1 complex.
The absolute values of the difference in averaged occu-
pancies in the bovine and bacterial bc1 complexes are shown
in Fig. 8 C. This difference exceeds 80% for amino acid resi-
dues His-201, Ala-193, and Asn-32 (bovine numeration).
In the bovine bc1 complex, His-201 and Asn-32 are located
mostly within 3.5 A˚ of antimycin, but in the bacterial bc1
complex these amino acid residues are located farther than
3.5 A˚ away. Ala-193 is within 3.5 A˚ of antimycin only in
the bacterial bc1 complex, and does not interact with anti-
mycin in the bovine bc1 complex. In addition to these three
amino acid residues, Fig. 8 C also shows many other amino
acid residues that interacted differently in bovine and bacte-
rial bc1 complexes during the MD simulations. However, inmany cases, the differences between the bovine and bacte-
rial bc1 complexes are not significantly higher than the
differences between antimycin binding sites in the same
bc1 dimer. Therefore, from our relatively short MD simula-
tions, it is difficult to assign all of these mismatches to
differences between bovine and bacterial bc1 complexes.
Nevertheless, it is clear that in addition to Lys-227, His-
201, Ala-193, and Asn-32, many other amino acid residues
interact differently with antimycin in bovine and bacterial
bc1 complexes.
In addition to these differences, weaker binding of
antimycin in bacteria could also be due to differences in
antimycin’s interaction with water. Specifically, the waters
involved in the contacts with His-201 and Lys-227 are
present in the two bovine structures but not in the bacterial
one (12,17,21). However, our MD simulations indicate that
the occupancy of water molecules near His-201 and Lys-227
in bovine structures does not exceed 30%, so any difference
in water occupancy near His-201 and Lys-227 between
bovine and bacterial complexes is not the main effect that
determines the weaker binding of antimycin in bacteria.
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